Quantcast

Latest Osteonecrosis of the jaw Stories

2011-07-26 00:00:30

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, is eagerly awaiting the report of an FDA panel being convened in September to discuss Fosamax, and specifically whether the drug increases incidence of throat cancer. New York, NY (PRWEB) July 25, 2011 According to an article published by Bloomberg on July 21, in advance of an advisory panel meeting on September 9 to discuss the long-term safety of drugs used to treat...

2011-07-15 06:01:00

THOUSAND OAKS, Calif., July 15, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has granted marketing authorization for XGEVA® (denosumab) for the prevention of skeletal-related events (SREs) (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors. This approval of XGEVA applies to all 27 European Union (EU) member states. The EC also granted XGEVA...

2011-06-06 17:29:39

To fully optimize a drug therapy for osteoporosis and low bone mineral density (BMD), patients should maintain vitamin D levels above the limits recently recommended by the Institute of Medicine (IOM), according to a new study by researchers from Hospital for Special Surgery in New York. The study will be presented at the Endocrine Society's Annual Meeting in Boston, June 4-7. The study demonstrated that maintaining a circulating vitamin D level above 33 ng/ml is associated with a seven-fold...

2011-06-01 00:24:00

EAST HANOVER, N.J., June 1, 2011 /PRNewswire/ -- Novartis Pharmaceuticals Corporation ("Novartis") will showcase data from 140 abstracts on its current oncology products and investigational agents at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO). These data underscore the company's commitment to developing treatments to improve the lives of patients with cancer. "Through our commitment to R&D and collaborations with the scientific and patient communities,...

2011-05-20 06:30:00

THOUSAND OAKS, Calif., May 20, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended a positive opinion for the marketing authorization of XGEVA(TM) (denosumab) for the prevention of skeletal-related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors. If approved by the...

2011-05-11 00:00:27

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, is considering the likelihood of consolidation of federal lawsuits against manufacturer Merck for pretrial proceedings in light of recent opposition voiced by some plaintiffs. New York, NY (PRWEB) May 09, 2011 On March 23, 2011, Merck moved the Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federal Fosamax lawsuits into a single Multidistrict...

2011-05-06 00:00:31

Fosamax®, a prescription osteoporosis drug for men and women has recently been linked by medical research, with weakened bones that can lead to spontaneous, low-energy bone breaks. The Spangenberg law firm is currently investigating potential lawsuits on behalf of current or former Fosamax users who have suffered from these unusual low-energy (or "atypical") bone fractures. Cleveland, OH (PRWEB) May 05, 2011 Recent medical research has linked Fosamax®, a prescription drug used to...

2011-04-12 10:40:00

NEW YORK, April 12, 2011 /PRNewswire-USNewswire/ -- The Bone and Cancer Foundation (BCF) provides information for cancer patients who have bone related complications including metastasis and cancer treatment induced bone loss. BCF patient publications cover very timely topics including Vitamin D and new treatment options, and are the only publications available that deal specifically with bone metastasis and cancer treatment induced bone loss. The following patient publications have been...

2011-04-12 00:00:29

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, is warning those whose doctors advise time off from taking the drug to speak with legal counsel sooner rather than later, because an interruption in dosing might not result in a pausing of the time to sue for harms caused by the medication. New York, NY (Vocus/PRWEB) April 11, 2011 Despite being the most popular osteoporosis treatment medication on the market, Fosamax...

2011-03-23 15:06:00

THOUSAND OAKS, Calif., March 23, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced new long-term data showing that during the fourth and fifth years of Prolia® (denosumab) treatment, postmenopausal women with osteoporosis receiving Prolia continued with further, statistically significant, year-over-year increases in lumbar spine and total hip bone mineral density (BMD), a key measurement of bone strength. The overall adverse event profile was similar for the...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin